EVENTIDE ASSET MANAGEMENT, LLC

Position in RPRX — Royalty Pharma plc

CIK 1442891 Boston, MA

Position in RPRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$62,962,255

+$12,852,899 QoQ

Shares Held

1,312,534

+1.2% QoQ

Ownership

0.228%

of shares outstanding

% of Portfolio

1.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

EVENTIDE ASSET MANAGEMENT, LLC holds $1,508,394,820 across 48 Biotechnology names. RPRX ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	1,408,871	$130,151,502
2	SRRK	Scholar Rock Holding Corp	2,197,385	$108,023,446
3	ARGX	Argenx SE	125,657	$91,761,024
4	INSM	INSMED Inc	546,310	$89,332,611
5	AXSM	Axsome Therapeutics, Inc.	519,558	$87,815,693
6	PCVX	Vaxcyte, Inc.	1,374,292	$79,860,108
7	RPRX	Royalty Pharma plc This page	1,312,534	$62,962,255
8	BLTE	Belite Bio, Inc	357,650	$57,023,716

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$62,962,255	1,312,534	+1.2%	Shares	Sole	2026-05-15
2025-12-31	$50,109,356	1,296,826	+41.5%	Shares	Sole	2026-02-13
2025-09-30	$32,333,731	916,489	-0.6%	Shares	Sole	2025-11-14
2025-06-30	$33,206,653	921,639	+4.8%	Shares	Sole	2025-08-14
2025-03-31	$27,388,454	879,809	+6.9%	Shares	Sole	2025-05-15
2024-12-31	$21,004,678	823,390	+6.6%	Shares	Sole	2025-02-14
2024-09-30	$21,857,504	772,623	+3.1%	Shares	Sole	2024-11-14
2024-06-30	$19,767,743	749,630	+8.5%	Shares	Sole	2024-08-13
2024-03-31	$20,976,164	690,687	+29.3%	Shares	Sole	2024-05-15
2023-12-31	$14,999,357	533,975	-46.8%	Shares	Sole	2024-02-20
2023-09-30	$27,252,522	1,004,146	-3.4%	Shares	Sole	2023-11-14
2023-06-30	$31,960,931	1,039,718	-0.9%	Shares	Sole	2023-08-15
2023-03-31	$37,799,541	1,049,113	+40.2%	Shares	Sole	2023-05-15
2022-12-31	$29,577,676	748,423	—	Shares	Sole	2023-02-13
No filing history on record for this holder in this stock.